GIFLF:OTCMKTS
Grifols
US$Â 11,13
0,00%
(0,00) 1D
15 sep, 15:11:14 GMT-4 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor GIFLF genereren…
Beursw.
6,59Â mld.
Gem. vol.
543,00
Volume
0,00
52 wk hoog
US$Â 12,90
52 wk laag
US$Â 10,13
Bèta
0,90
Uitstaande aandelen
426,13Â mln.
Aantal medewerkers
25K
Beursw.
6,59Â mld.
Gem. vol.
543,00
Volume
0,00
52 wk hoog
US$Â 12,90
52 wk laag
US$Â 10,13
Bèta
0,90
Uitstaande aandelen
426,13Â mln.
Aantal medewerkers
25K
Nieuwsartikelen
Van webbronnen en nieuwspartners
AD HOC NEWS
·
4 uur geleden
Grifols stock after-hours at EUR 9.88: plus 0.51 percent
AD HOC NEWS
·
11 uur geleden
Grifols signed a 40 GWh PPA and Grifols stock gained 1.22 percent
AD HOC NEWS
·
1 dag geleden
Grifols stock was upgraded as first-half profit rose
AD HOC NEWS
·
1 dag geleden
Grifols stock pre-market: EUR 9.84, prior close EUR 9.87
Profiel
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Over Grifols